Sanofi-Aventis settles drug pricing case
Pharma Compliance Alert, September 12, 2007
Sanofi-Aventis paid federal and state governments more than $190 million to settle allegations that the company caused false claims to be filed with Medicare and other governmenthealth programs as a result of the company's alleged fraudulent pricing and marketing of drugs.
Ven-A-Care of the Florida Keys Inc., a home-infusion company, filed the False Claims Act suit that started the investigation into the pricing of Anzement, an antiemetic drug used primarily in conjunction with oncology and radiation treatment to prevent nausea and vomiting.
The suit alleged Aventis inflated prices that it reported. Because reimbursement from federal programs was based on the fraudulent, inflated prices, the United States contended Aventis caused false and fraudulent claims to be submitted to federal healthcare programs.
Of the more than $190 million settlement, the federal recovery is $179,787,726, and the states' and District of Columbia's recovery for their share of Medicaid is $10,645,600.
To read more, click here.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched